The clinical, haematological and morphological profile of patients with myelodysplastic syndromes: A single institution experience from Turkey
Authors:
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 48 (7) , 1372-1378
Abstract
In a retrospective analysis of 113 patients with primary myelodysplastic syndromes (MDS) diagnosed according to French-American-British (FAB) classification, we evaluated the prognostic impact of FAB and World Health Organisation (WHO) classifications, International Prognostic Scoring System (IPSS), and other clinical and laboratory variables. The median age was 69. IPSS could be applied to 75 patients classified according to the FAB criteria and to 50 patients reclassified according to the WHO criteria. At a median follow-up of 24 months, 22 patients (19.5 %) transformed to acute myelogenous leukaemia (AML). Overall survival (OS) of patients differed significantly between the FAB and WHO subgroups (p < 0.0001). In WHO classification, significant differences were observed in both OS and leukaemia free survival (LFS) between patients with RA/RARS and refractory cytopenia with multi-lineage dysplasia/refractory cytopenia with multi-lineage dysplasia and ringed sideroblasts (RCMD/RS-RCMD) (p = 0.0001). High-risk according to IPSS score and blood transfusion need were significantly predictive for a shorter survival and higher risk of transformation. Hemoglobin 9/L, platelet count 9/L had an unfavourable prognostic impact on survival in multi-variate analysis. Our conclusions support the previous findings on the value of WHO classification for prediction of prognosis in MDS.Keywords
This publication has 18 references indexed in Scilit:
- Myelodysplasic syndromes: A comprehensive reviewBlood Reviews, 2005
- Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision MakingJournal of Clinical Oncology, 2005
- The myelodysplastic syndromes: Diagnosis, molecular biology and risk assessmentHematology, 2005
- A Comparative Review of Classification Systems in Myelodysplastic Syndromes (MDS)Seminars in Oncology, 2005
- Myelodysplastic Syndromes — Coping with Ineffective HematopoiesisNew England Journal of Medicine, 2005
- Clinical, haematological and histomorphological profile of adult myelodysplastic syndrome. Study of 96 cases in a single instituteEuropean Journal of Haematology, 2004
- Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classificationsLeukemia Research, 2004
- The WHO classification of MDS does make a differenceBlood, 2004
- Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndromeLeukemia, 2003
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976